Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 0.03% Nasdaq Up 0.03%
Streaming
Ticker Tape: On

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS

22.81 Down 0.27(1.17%) 10:31AM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:23.08
Open:23.03
Bid:22.88 x 200
Ask:22.96 x 300
1y Target Est:19.71
Beta:1.65
Next Earnings Date: 7-Aug-13ISIS Earnings announcement
Day's Range:22.73 - 23.03
52wk Range:7.56 - 24.04
Volume:71,900
Avg Vol (3m):1,514,250
Market Cap:2.37B
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 1.17%2.37B
NVODown 0.50%86.94B
TEVADown 0.66%33.58B
AGNDown 0.36%29.95B
FRXDown 0.05%11.11B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.73
Quarterly EPS Est (Jun-13) :-0.21
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-1.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product, KYNAMRO injection, is an apo-B synthesis inhibitor for patients with homozygous famili... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback